ters of the glomerulus and the implications for diabetic hephropathy. Kidney Int，1997,52(Suppl):S91-S99.
15 King GL, Ishii H,Koya D.Diabetic Vascular dysfunctions:a moelel of excessive activadion of protein Kinase C.Kidney Int,1997,52(Suppl60):S77-S85.
16 Babazono T,Kapor-Drezgic J, Diugosz JA, et al.Altered expression and subcelluler localization of diacylglycerol-sensitive protein Kinase C isoforms in diabetic rat glomerular cells.Diabetes,1998,47 :668-676.
17 姚丽,周华,王力宁，等.蛋白激酶C同工酶在糖尿病肾病肾小球的表达.中华肾脏病杂志,2002,18(2):127-130.
18 Mulec H,Johnson SA,Bjorck S.Relationship between serum cholesterol and diabetic nephropathy. Lancet,1990,1:1537-1538.
19 Tolins JP,Stone BG,Raiz L.Interactions of hypercholesterolemia and hypertension in initiation of glomerular injury.Kidney Int,1992,41:1254-1261.
20 Grandallano G,Biswas P,Choudhury GG,et al.Simvastatin inhibits PDGF-induced DNA synthesis in human glomerular mesangial cells.Kidney Int,1993,44:503-509.
21 李航，李学旺，段琳，等.洛伐他汀对系膜细胞核因子-κB活性及炎症细胞因子表达的影响.中华肾脏病杂志，2001，17(4)：242-245.
22 陈丽萌，李学旺，林嘉友，等. 洛伐他汀对高糖时人肾小管上皮细胞核因子-κB和组织纤溶酶原激活物及其抑制物的作用，中华肾脏病杂志，2001，17(6)：399-403.
23 Ghosh PM,Mott GE,Ghosh-Choudhury N,et al. Lovastatin induces apoptosis by inhibiting mitotic and post-mitotic events in cultured mesangial cells. Biochim Biophys Acta,1997,1359:13-24.
上一页 [1] [2] [3] [4] [5] [6] [7] [8]
您现在的位置： 绿色健康网 >> 医学论文 >> 内科论文 >> 正文